Mirabegron (BetmigaT) launched in the UK for overactive bladder
Source: Press release - Astellas Pharma Europe
Area: News
Mirabegron (BetmigaT) is now available in the UK for the symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome. The recommended dose is 50mg once daily with or without food.
Mirabegron is available as 25mg and 50mg prolonged-release tablets (NHS list price for both strengths: £29 for 30 tabs).
Please see SPC for prescribing details.
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Incontinence | Overactive Bladder | Overactive Bladder Syndrome | Pharmaceuticals